Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota–derived short-chain fatty acids and kidney diseases
Lingzhi Li, Liang Ma, Ping Fu
Drug Design Development and Therapy (2017) Vol. Volume 11, pp. 3531-3542
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

The role of short-chain fatty acids in microbiota–gut–brain communication
Boushra Dalile, Lukas Van Oudenhove, Bram Vervliet, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 8, pp. 461-478
Open Access | Times Cited: 2177
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Tao Yang, Elaine M. Richards, Carl J. Pepine, et al.
Nature Reviews Nephrology (2018) Vol. 14, Iss. 7, pp. 442-456
Open Access | Times Cited: 555
Distant Organ Dysfunction in Acute Kidney Injury: A Review
Sul A Lee, Martina Cozzi, Errol L. Bush, et al.
American Journal of Kidney Diseases (2018) Vol. 72, Iss. 6, pp. 846-856
Open Access | Times Cited: 225
Intestinal microbiome and fitness in kidney disease
Björn Meijers, Pieter Evenepoel, Hans‐Joachim Anders
Nature Reviews Nephrology (2019) Vol. 15, Iss. 9, pp. 531-545
Open Access | Times Cited: 163
Mechanisms of Short-Chain Fatty Acids Derived from Gut Microbiota in Alzheimer's Disease
Xiao-hang Qian, Ru-yan Xie, Xiaoli Liu, et al.
Aging and Disease (2022) Vol. 13, Iss. 4, pp. 1252-1252
Open Access | Times Cited: 75
Gut microbial metabolites SCFAs and chronic kidney disease
He Meng, Wenqian Wei, Yichen Zhang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Interaction between gut microbiome and cardiovascular disease
Jieting Peng, Xun Xiao, Min Hu, et al.
Life Sciences (2018) Vol. 214, pp. 153-157
Closed Access | Times Cited: 145
Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition
Sibei Tao, Lingzhi Li, Ling Li, et al.
Acta Diabetologica (2019) Vol. 56, Iss. 5, pp. 581-592
Closed Access | Times Cited: 144
Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease
Siqi Wang, Dan Lv, Shuanghong Jiang, et al.
Clinical Science (2019) Vol. 133, Iss. 17, pp. 1857-1870
Closed Access | Times Cited: 108
Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus
Mengchen Guo, Huixia Wang, Sixie Xu, et al.
Gut Microbes (2020) Vol. 11, Iss. 6, pp. 1758-1773
Open Access | Times Cited: 96
Gut-on-chip: Recreating human intestine in vitro
Yunqing Xiang, Hui Wen, Yue Yu, et al.
Journal of Tissue Engineering (2020) Vol. 11
Open Access | Times Cited: 92
Protective effects of tuna meat oligopeptides (TMOP) supplementation on hyperuricemia and associated renal inflammation mediated by gut microbiota
Jiaojiao Han, Xiaofeng Wang, Shasha Tang, et al.
The FASEB Journal (2020) Vol. 34, Iss. 4, pp. 5061-5076
Closed Access | Times Cited: 75
Multiple roles of short-chain fatty acids in Alzheimer disease
Hui Chen, Lei Meng, Liang Shen
Nutrition (2021) Vol. 93, pp. 111499-111499
Closed Access | Times Cited: 67
Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation
Giorgia Magliocca, Pasquale Mone, Biagio Di Iorio, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5354-5354
Open Access | Times Cited: 62
Effects of microbial-derived biotics (meta/pharma/post-biotics) on the modulation of gut microbiome and metabolome; general aspects and emerging trends
Alireza Sadeghi, Maryam Ebrahimi, Mohammad Saeed Kharazmi, et al.
Food Chemistry (2023) Vol. 411, pp. 135478-135478
Closed Access | Times Cited: 24
The Kidney–Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression
Sandra Cabała, M. Ożgo, Agnieszka Herosimczyk
Metabolites (2024) Vol. 14, Iss. 1, pp. 78-78
Open Access | Times Cited: 14
Mitochondrial function and abnormalities implicated in the pathogenesis of ASD
Frank J. Castora
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 92, pp. 83-108
Closed Access | Times Cited: 75
Improvement of Colonic Immune Function with Soy Isoflavones in High-Fat Diet-Induced Obese Rats
Qihui Luo, Dongjing Cheng, Chao Huang, et al.
Molecules (2019) Vol. 24, Iss. 6, pp. 1139-1139
Open Access | Times Cited: 68
The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease
Yu Liu, Xi Jin, Hyokyoung G. Hong, et al.
The FASEB Journal (2020) Vol. 34, Iss. 8, pp. 11200-11214
Open Access | Times Cited: 67
Short-Chain Fatty Acids: A Soldier Fighting Against Inflammation and Protecting From Tumorigenesis in People With Diabetes
Qiyu Yang, Jing Ouyang, Fengjun Sun, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 59
More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling
Shreyasi Gupta, Utpal Sen
Pharmacological Research (2019) Vol. 147, pp. 104391-104391
Open Access | Times Cited: 54
The effect of short-chain fatty acids on M2 macrophages polarizationin vitroandin vivo
Chunrong Huang, Wei Du, Yingmeng Ni, et al.
Clinical & Experimental Immunology (2021) Vol. 207, Iss. 1, pp. 53-64
Open Access | Times Cited: 41
Gut Microbiome and Organ Fibrosis
Carolina F. F. A. Costa, Benedita Sampaio‐Maia, Ricardo Araújo, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 352-352
Open Access | Times Cited: 36
Gut Microbiota Mediates the Protective Effects of Traditional Chinese Medicine Formula Qiong-Yu-Gao against Cisplatin-Induced Acute Kidney Injury
Ye‐Ting Zou, Jing Zhou, Jin‐Hao Zhu, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 34
Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease
Pan Zhang, Xifan Wang, Shenghui Li, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top